MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 53 filers reported holding MONTE ROSA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,126,578 | -27.5% | 443,962 | +3.6% | 0.00% | -100.0% |
| Q2 2023 | $2,935,150 | +50.4% | 428,489 | +71.0% | 0.00% | – |
| Q1 2023 | $1,951,605 | +0.5% | 250,527 | -1.8% | 0.00% | – |
| Q4 2022 | $1,941,395 | -4.2% | 255,111 | +2.8% | 0.00% | – |
| Q3 2022 | $2,027,000 | -6.3% | 248,150 | +10.9% | 0.00% | – |
| Q2 2022 | $2,164,000 | -29.8% | 223,765 | +1.8% | 0.00% | -100.0% |
| Q1 2022 | $3,081,000 | +39.5% | 219,738 | +103.2% | 0.00% | – |
| Q4 2021 | $2,209,000 | -4.7% | 108,165 | +4.0% | 0.00% | – |
| Q3 2021 | $2,317,000 | – | 103,997 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $33,422,000 | 5.35% |
| Cormorant Asset Management, LP | 3,193,973 | $69,550,000 | 2.36% |
| NEA Management Company, LLC | 7,703,205 | $174,863,000 | 2.28% |
| Octagon Capital Advisors LP | 238,045 | $5,404,000 | 1.12% |
| Avoro Capital Advisors LLC | 3,311,434 | $62,153,000 | 1.08% |
| Alphabet Inc. | 1,464,015 | $33,233,000 | 0.68% |
| Logos Global Management LP | 300,000 | $6,810,000 | 0.57% |
| Casdin Capital, LLC | 960,883 | $21,812,000 | 0.55% |
| RTW INVESTMENTS, LP | 1,214,572 | $25,228,000 | 0.38% |
| Monashee Investment Management LLC | 120,000 | $2,724,000 | 0.33% |